Integrated analysis of proteome and transcriptome profiling reveals pan-cancer-associated pathways and molecular biomarkers
{{output}}
Understanding dysregulated genes and pathways in cancer is critical for precision oncology. Integrating mass spectrometry-based proteomic data with transcriptomic data presents unique opportunities for systematic analyses of dysregulated genes and pathways in ... ...
